Clinical Trials on MUC17-positive Solid Tumors
Total 5403 results
-
Daiichi Sankyo, Inc.Medpace, Inc.Completed
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedSolid TumorsUnited States
-
Cascadian Therapeutics Inc.CompletedSolid TumorsUnited States
-
Ganymed Pharmaceuticals GmbHCompletedSolid TumorsGermany, Latvia
-
Regeneron PharmaceuticalsSanofiCompleted
-
University of Southern CaliforniaAstraZeneca; Celgene CorporationCompleted
-
National University Hospital, SingaporeCompleted
-
M.D. Anderson Cancer CenterCompleted
-
Alnylam PharmaceuticalsCompletedSolid TumorsUnited States, Spain
-
Genta IncorporatedCompleted
-
Axelar ABCompleted
-
AbbottCompletedSolid TumorsUnited States
-
Dana-Farber Cancer InstituteBoston Children's HospitalTerminated
-
Quanta TherapeuticsRecruiting
-
Boehringer IngelheimRecruiting
-
Merck Sharp & Dohme LLCActive, not recruitingSolid TumorsPoland, Korea, Republic of, United States, Argentina, Australia, Canada, Colombia, France, Germany, Guatemala, Israel, Italy, Japan, Latvia, Mexico, Peru, Puerto Rico, Romania, South Africa, Spain, Sweden, Turkey, Ukraine
-
University Health Network, TorontoBoehringer IngelheimCompleted
-
Bristol-Myers SquibbCompletedSolid TumorsUnited States, Australia, Spain, Germany, France, Switzerland, Netherlands, Canada, Belgium, Italy
-
Incyte Biosciences Japan GKTerminated
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...Unknown
-
AstraZenecaQuintiles, Inc.CompletedSolid TumorsUnited States, France, United Kingdom, Netherlands
-
Eli Lilly and CompanyCompletedSolid TumorsUnited States
-
Herbert Hurwitz, MDGlaxoSmithKline; National Comprehensive Cancer Network; Threshold PharmaceuticalsCompleted
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Washington University School of MedicinePfizerCompleted
-
Quintessence Biosciences, Inc.Unknown
-
Emory UniversityPfizer; Millennium Pharmaceuticals, Inc.Completed
-
Daiichi Sankyo, Inc.CompletedSolid TumorsUnited States
-
National University Hospital, SingaporeUnknown
-
University of ChicagoPfizerCompletedSolid TumorsUnited States
-
National University Hospital, SingaporeCompleted
-
Millennium Pharmaceuticals, Inc.CompletedSolid TumorsUnited States
-
Jazz PharmaceuticalsMerck Sharp & Dohme LLCRecruitingAdvanced Solid Tumor | Metastatic Solid TumorUnited States
-
PharmaEngineNot yet recruitingAdvanced Solid Tumor | Metastatic Solid Tumor
-
Daiichi SankyoRecruitingAdvanced Solid Tumor | Metastatic Solid TumorUnited States, Japan
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruitingAdvanced Solid Tumor | Malignant Solid TumorUnited States, Japan
-
Jazz PharmaceuticalsActive, not recruitingAdvanced Solid Tumor | Metastatic Solid TumorUnited States
-
Dana-Farber Cancer InstituteCompletedAdvanced Solid Tumor | Metastatic Solid TumorUnited States
-
Sidnei EpelmanUnknown
-
Vividion Therapeutics, Inc.RecruitingAdvanced Solid Tumors | Advanced Hematologic TumorsUnited States, Australia
-
OncoMed Pharmaceuticals, Inc.CompletedRefractory Solid Tumors | Advanced Relapsed TumorsUnited States
-
Baylor College of MedicineHarris County Hospital District; The Methodist Hospital Research InstituteWithdrawn
-
University of California, San FranciscoMerck Sharp & Dohme LLCCompletedCancer | Advanced Solid Tumors | TumorsUnited States
-
St. Jude Children's Research HospitalRecruitingSolid Tumor | CNS Tumor | ALL, AdultUnited States
-
AstraZenecaCompletedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
AstraZenecaTerminatedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
BeiGeneRecruitingSolid Tumor | Advanced Solid TumorUnited States, New Zealand, Australia, China